GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹1,705 Cr | ₹-1,757 Cr | ₹1,208 Cr | ₹-1,003 Cr | ₹-1,524 Cr |
What is the latest Cash Flow from Investing Activities ratio of GLAND PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹1,705 Cr |
| Mar2024 | ₹-1,757 Cr |
| Mar2023 | ₹1,208 Cr |
| Mar2022 | ₹-1,003 Cr |
| Mar2021 | ₹-1,524 Cr |
How is Cash Flow from Investing Activities of GLAND PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,705 Cr | Positive | |
| Mar2024 | ₹-1,757 Cr | Negative | |
| Mar2023 | ₹1,208 Cr | Positive | |
| Mar2022 | ₹-1,003 Cr | Negative | |
| Mar2021 | ₹-1,524 Cr | - | |
Compare Cash Flow from Investing Activities of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹30,770.6 Cr | 2.5% | 3.8% | 21.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 2.5% |
3.8% |
21.4% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses